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Abstract Objective: To assess the prediction of stone clearance and complications
of percutaneous nephrolithotomy (PCNL) using the ‘STONE’ nephrolithometry
score, assessing stone size, tract length (skin-to-stone distance), degree of obstruc-
tion, number of calyces involved and stone essence (density).
Patients and methods: This was a prospective study of patients undergoing single-
tract PCNL while prone, conducted at a university hospital. All patients had non-
contrast-enhanced computed tomography within 3 weeks of the procedure. Only
patients with a unilateral procedure and radio-opaque stones were included. The five
variables of the STONE nephrolithometry score were calculated before the proce-
dure. The stone-free rates were assessed with a plain abdominal film at 4 weeks
and complications were graded using the modified Clavien system.
Results: In all, 107 patients were included in the final analysis. Overall, 80% of
patients were rendered stone-free. Among the individual variables, a larger stone
(P= 0.002) and the involvement of multiple calyces (P= 0.04) were associated with
residual stones, while tract length (skin-to-stone distance), stone density and presence
of hydronephrosis were not. Patients who were rendered stone-free had a statistically
significant lower overall STONE score than those with residual stones, at 7.24 vs. 8.14
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enhanced CT;
SFR, stone-free rate
(P= 0.02). The score also correlated with operative duration, which was significantly
longer with a higher STONE score (P= 0.03). The complication rate was 18% and
most complications were Clavien grade 2, with bleeding requiring a blood transfusion
(11 patients) being the commonest. There were no deaths within 30 days of surgery,
but there was no correlation between the STONE score and complications.
Conclusion: The STONE nephrolithometry score is a simple and easy to apply
system for predicting complexity in stone clearance with PCNL.
 2015 Arab Association of Urology. Production and hosting by Elsevier B.V. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
Introduction
Despite the availability of guidelines for managing
urolithiasis there is no widely accepted standardised sys-
tem for classifying stones in the upper urinary tract [1].
With the marked increase in the incidence and preva-
lence of renal stones, the use of percutaneous
nephrolithotomy (PCNL) is now considered as the stan-
dard treatment for large and complex renal stones [2,3].
Recently, Okhunov et al. [4] proposed a novel quantita-
tive scoring systemwhich integrates five components mea-
sured from non-contrast-enhanced CT (NCECT) images
before surgery to provide a picture of the complexity that
can affect the percutaneous management of renal calculi.
The stone score is calculated using five variables, abbrevi-
ated as an acronym ‘STONE’. These include stone size,
tract length (skin-to-stone distance), degree of obstruction,
number of calyces involved and stone essence (density).
The scoring system can be used as a standard method for
predicting the stone-free rate (SFR) after PCNL, and help
in preoperative patient counselling, surgical planning and
uniform academic reporting of the outcome. However,
other investigators have not validated the study by
Okhunov et al. [4]. Thus we prospectively analysed and
report the use of the STONE nephrolithometry score for
evaluating the outcome of PCNL.
Patients and methods
This was a prospective study conducted by the section of
Urology at the Aga Khan University Hospital, Karachi,
Pakistan. An institutional review board approved the
study, and all adult patients (>18 years) who underwent
unilateral, single-tract PCNL for radio-opaque calculi,
and had NCECT at our institute before surgery, were
included. We excluded patients with radiolucent stones,
bilateral renal stones, a history of previous surgery on
the ipsilateral kidney, the presence of a nephrostomy
tube or ureteric stent, active UTI, coagulopathy, skeletal
deformity or special/abnormal anatomy of the upper
tract (i.e., horseshoe kidney, PUJ obstruction, bifid or
double system, etc.).
The demographic, clinical and operative data were
collected and information including age, sex, body mass
index (BMI), laterality, operative duration and hospital
stay was prospectively collected. All patients had
abdominal CT using a 64-slice machine (Aquilion,
Toshiba Medical Systems, Shimoishigami, Otawara-
Shi, Japan) within 3 weeks of PCNL, with 3-mm axial
and reformatted 3-mm coronal sections evaluated on a
picture-archiving computer system (View Pro-X version
4.0.6.2; Rogan-Delft, Veenendaal, Holland).
The CT variables proposed by Okhunov et al. [4],
i.e., stone size, tract length, degree and presence of
obstruction (hydronephrosis), number of involved
calyces and stone essence (density), were measured
by one experienced radiologist. Each of the variables
was scored according to the predefined system pro-
posed by Okhunov et al., and the STONE
nephrolithometry score calculated using the sum of
individual variable scores.
All procedures were performed with the patient
prone, using single-tract dilatation with Alken dilators
under fluoroscopic guidance. The technique of PCNL
was described earlier [5]. Stones were fragmented using
either the LithoclastTM (Richard Wolf GmbH,
Knittlingen, Germany), or simultaneous combined ther-
apy with the Lithoclast and an ultrasonic lithotripter
(Richard Wolf GmbH). The procedure was continued
until no stone could be identified by both nephroscopic
and fluoroscopic inspection. A flexible cystoscope (0,
5 mm, 15 F, Karl Storz, Germany) and holmium-YAG
laser (Lumenis Versapulse, 265 lm fibre) was used to
access difficult locations. The patients were assessed
for the presence of any residual stone by follow-up
imaging with a plain abdominal film, and a stone-free
status was defined as complete clearance, with no visible
fragments or stone fragments of 62 mm at 1 month
after surgery.
Data were analysed statistically by univariate analy-
sis, between stone-free and patients with residual stone.
Student’s t-test was used to compare continuous vari-
ables and the chi-squared test for categorical variables.
In all tests, P< 0.05 was considered to indicate signifi-
cant differences. The primary outcome of the study was
to determine the SFR and compare it with individual
variables and the sum of the STONE score for clear-
ance. The secondary outcome was to evaluate the ability
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of this scoring system to predict peri/postoperative com-
plications within 30 days of the procedure. All complica-
tions were classified according to modified Clavien
grading system.
Results
From April 2014 to September 2014, 167 patients were
treated by PCNL and of these, 107 qualified for inclu-
sion and were assessed in the final analysis. The mean
(SD) age at presentation was 45.2 (17.5) years and the
mean BMI was 27.5 (4.9) kg/m2. The study population
comprised mainly men (62%) and the side of the proce-
dure was almost equal. The patients’ demographics and
stone characteristics evaluated for the STONE score are
shown in Table 1.
Overall, 86 patients (80%) were rendered stone-free.
Significantly many stones which were cleared were smal-
ler than those that were not completely cleared. Among
the individual variables, a larger stone (P= 0.002) and
involvement of multiple calyces (P= 0.04) were associ-
ated with residual stones, while tract length, stone den-
sity and presence of hydronephrosis were not
(Table 1). In all, 28% of patients had a longer tract
(>100 mm), of whom nearly 87% were stone-free, com-
pared to 80% of those with shorter tracts (<100 mm;
P = 0.306). Nearly half of the patients had
hydronephrosis but the stone clearance rate was almost
equal between them and those with no hydronephrosis
(P = 0.771). Nearly two-thirds of the patients had
harder stones (>950 Hounsfield units) with a slightly
lower SFR (78%) than the 85% in those with softer
stones (<950 units; P = 0.35). Patients who were ren-
dered stone-free had a statistically significantly lower
overall STONE score than those with residual stones
(P = 0.02). The score also correlated with the operative
Table 1 The demographic and clinical data of the 107 patients, and the stone characteristics
used to calculate the STONE score.
Variable, total, n (%) Group, mean (SD) or n (%)
Stone-free Residual stone P
Outcome 86 (80.4) 21 (19.6) –
Age, years 45.3 (17.0) 44.6 (17.0) 0.860
Gender
Male 51 (77) 15 (23) 0.450
Female 35 (85) 6 (15)
BMI (kg/m2) 28 (5) 26.3 (3) 0.080
Side 0.020
Right, 55 (51) 49 (89) 6 (11)
Left, 52 (49) 37 (71) 15 (29)
STONE score 7.24 (1.5) 8.14 (2.0) 0.023
Size (mm2) 0.002
0–399, 82 (77) 71 (87) 11 (13)
400–799, 14 (13) 10 4
800–1599, 7 (7) 2 5
P1600, 4 (4) 3 1
Tract length (mm) 0.306
<100, 77 (72) 60 (78) 17 (22)
>100, 30 (28) 26 (87) 4 (13)
Obstruction 0.771
None, 53 (50) 42 (79) 11 (21)
Severe, 54 (51) 44 (82) 10 (19)
No. of calyces involved 0.040
1–2, 59 (55) 52 (88) 7 (12)
3, 32 (28) 24 (75) 8 (25)
Staghorn, 16 (15) 10 6
‘Essence’ (Hounsfield units) 0.350
<950, 40 (37) 34 (85) 6 (15)
>950, 67 (63) 52 (78) 15 (22)
Length of stay (days) 3.9 (2.1) 3.8 (1.1) 0.800
Op. duration (min) 89.6 (20.7) 101.2 (27.3) 0.030
Figure 1 A plot of the relationship between the individual
STONE scores and the SFR.
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duration, being significantly longer with a higher
STONE score (P = 0.03; Table 1).
Fig. 1 is a plot of the stone clearance rate with
STONE score, and shows that rate decreased with
increasing score, except for the overall score of 13 in
one patient who had complete clearance.
Among patients with residual stones, six (29%) had
additional treatments, with shock-wave lithotripsy in
four and semi-rigid ureteroscopy and JJ stenting in
one each. None of the patients had a repeat PCNL.
Overall, 19 patients (18%) had peri/postoperative com-
plications, including one of Clavien grade 1, 11 of
Clavien grade 2, four of Clavien grade 3a, and three
of Clavien grade 3b (Table 2). The most common com-
plication was bleeding requiring a blood transfusion, in
11 patients. There were no deaths within 30 days of sur-
gery, but there was no correlation between the STONE
score and complications.
Discussion
In the general population the incidence of urolithiasis is
5–10%, and nearly 30% of the workload in an active
urology department is related to treating urinary stones
[6]. For large and complex kidney stones PCNL is an
important surgical intervention, and its success depends
on several variables. Some of these can be predicted
before surgery, i.e., stone burden and upper tract anat-
omy, but success also depends on surgical experience [7].
To establish an accurate diagnosis and to determine
the optimum treatment and surgical planning, preoper-
ative imaging is a critical step [8]. CT has become the
leading imaging method for urolithiasis, providing
high-resolution spatial imaging along with multi-
planar reconstruction for the accurate determination
of stone complexity, i.e., size and distribution, pelvi-
calyceal anatomy and anatomical relationship with
other structures, hence contributing to surgical planning
[9,10].
Several scoring systems have been developed for pre-
dicting the SFR after shock-wave lithotripsy, retrograde
intrarenal surgery and PCNL [11,12]. These have
incorporated different variables that can influence suc-
cess rates, but the imaging methods on which these sys-
tems are developed show some inconsistencies [13].
The scoring systems in contemporary use for predict-
ing the outcome of PCNL are Guy’s stone score, the
STONE nephrolithometry score, the Clinical Research
Office Of Endo-Urological Society (CROES)
nephrolithometric nomogram, and staghorn morphome-
try. These have attempted to incorporate important vari-
ables in an efficient and simple manner to quantify renal
stone complexity [13]. An optimal scoring system should
be quick, simple, reproducible and easily implemented,
and must have a good correlation with SFRs and compli-
cations [14]. It also helps to define the complexity of the
stone, and benefit not only patient counselling, but also
auditing, training and revalidation, and comparison
between different centres, surgeons and techniques by
uniform and standardised reporting [15–18].
The Guy’s score and CROES nomograms were ini-
tially developed using abdominal plain films, while the
staghorn morphometry score and STONE score were
developed on the basis of CT findings of variables that
can be obtained specifically from CT. The Guy’s stone
score includes stone number, location, presence of stag-
horn stones and abnormal anatomy to determine differ-
ent grades, and it was reported that the SFR declined
with increasing grades of complexity [14]. Mishra et al.
[19] proposed a classification system for staghorn stones
using the stone volume and its distribution in the collect-
ing system. This ‘staghorn morphometry’ requires CT
urography and CT-based volumetric assessment soft-
ware that is complex to adapt. This was done to improve
the prediction of efficacy, reduce the morbidity, and to
plan PCNL with respect to the requirement for tracts
and stage(s) of PCNL. By contrast, Smith et al. [7],
based on a multivariate analysis, reported a
nephrolithometric nomogram (CROES) that also takes
into account patient and surgeon factors, i.e., previous
surgery and the case volume of surgeons.
Okhunov et al. [4] developed and validated the
STONE score from preoperative NCECT, based on a
Medline review of English-language studies from 1976
to 2012 and identifying clinically relevant variables
affecting the outcomes of PCNL. This scoring system
was externally validated in a multi-institutional study
with 850 patients, and showed that the model was signif-
icantly associated with the SFR, overall complication
rate, estimated blood loss, operative duration and length
of hospital stay [20]. In contrast to the other scoring sys-
tems, the STONE score uses variables that are easy to
calculate, derived from NCECT (most common diag-
nostic method used for evaluating patients with stone)
and requires no specialised software.
In the present study, tract length, BMI and the degree
of obstruction were not associated with a lower SFR.
Others have reported that patients with a greater BMI
Table 2 Complications of PCNL classified according to
modified Clavien grading system.
Grade Complication n
1 Transient elevation of creatinine 1
2 Blood transfusion 8
Urine leakage <24 h 2
Fever (UTI) requiring change of antibiotic 1
3a Bleeding requiring Transfusion + 3
Angio-embolisation due to AV fistula or pseudo-
aneurysm
3
Urinary retention + colic due to blood clots 1
3b Cystoscopic evacuation of clots 2
Prolonged leakage requiring JJ stenting 1
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and consequently longer tract (skin-to-stone distance)
will be technically challenging, and this could affect
the peri-operative variables.
Zhu et al. [21], in a multivariate analysis, showed that
greater obstruction and consequent hydronephrosis lead
to lower success rates. This variable was not significant
in the present study, because although stone fragments
might migrate and scatter from the original sites to the
other remote areas of the collecting system, a dilated
system is also easy to puncture.
The present patients were different from those
assessed by Okhunov et al. [4], being younger and with
a higher mean STONE score of 7.24, compared to 6.8
in their stone-free group, but a lower score of 8.14 vs.
9.7 in those with residual stone. The mean operative
duration in the stone-free group was comparable to that
reported by Okhunov et al., but it was shorter in those
with residual stone. The complication rates were
comparable.
Okhunov et al. [4] reported the STONE score to
be highly predictive of the SFR, with an accuracy
of 83.1% that was greater than any of the other
individual variables. Similarly, in another study,
Okhunov et al. [22] reported an excellent interob-
server reliability of the STONE system among med-
ical students, urology residents, fellows and
attending urologists.
We did not determine the accuracy of the score, nor
did we assess the interobserver reliability, but we found
this scoring system to correlate with the SFR, with lower
scores predicting the likely probability of stone clear-
ance. Although the difference between mean STONE
score of the stone-free and residual-stone group was sig-
nificant, it was small (<1 point). Similarly, a higher
STONE score, with a more complex procedure, was cor-
related with a longer operation; it was not reflected in a
greater likelihood of complications.
The CROES PCNL global study reported a success
rate of 75.5% and a complication rate of 20.5% [3].
They proposed that a higher stone burden, and com-
plexity, are associated with lower SFRs and higher com-
plication rates. Our results are comparable with these
results. The overall complication rate of 18% is compa-
rable to contemporary series and most complications
were minor (Clavien grade 1 and 2). There was bleeding
requiring transfusion in 10% of patients, higher than the
5.7% reported in a multicentre study by CROES [3].
The possible reason for this higher transfusion rate
could be a lower baseline haemoglobin level and conse-
quently a lower reserve and threshold for transfusion.
One of the most devastating complications of PCNL is
injury to surrounding organs, most commonly large
bowel injury [23].
The main limitation of the present study was the rel-
atively few patients included. For this reason, the vast
majority of the patients (79 of 107) can be sub-
classified into those with a ‘moderate complexity score
of 6–8’, according to the study of Okunov et al. [4], while
only nine and 19 could be sub-classified into the ‘low
complexity’ score of 3–5 and ‘high complexity’ score
of 9–13, respectively. This might also explain why the
difference between the stone-free patients and those with
residual stone was <1 point. Interestingly, the low-
complexity group had a SFR of 67%. This could be
related to the expertise of three different urologists per-
forming the procedure. However, this factor was not
separately assessed in the present study. It was a
single-centre study done within a short period with few
patients. There was no correlation between the preva-
lence of complications and the STONE score, possibly
because there were too few patients. A larger-scale
multi-centre study should be undertaken to validate
and confirm our results.
In conclusion, the STONE score is a simple and easy
to apply system for predicting the complexity of the
stone for PCNL, and stone clearance. Prospective stud-
ies with a larger sample are required to further confirm
these findings.
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